Trial Profile
Single Dose Preliminary Dose-ranging and Safety in Patients With COPD
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Sep 2014
Price :
$35
*
At a glance
- Drugs Olodaterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 05 Nov 2010 New trial record.